AACR COVID-19 and Cancer Virtual Meeting: Tracking the Evolution and Spread of SARS-CoV-2
In January, when most of us in the United States were busy living the hustle and bustle of everyday life, one shrewd virologist and computer biologist saw...
In January, when most of us in the United States were busy living the hustle and bustle of everyday life, one shrewd virologist and computer biologist saw...
Krista Holmes, who survived cancer as a child, is now an AACR Ambassador for Runners to Research. She shared...
Our five senses provide us with the crucial information we need to interact with the world. On a physiological...
Karriem Watson is a public health expert serving as chief engagement officer of the National Institutes of Health’s All...
Imagine your DNA as a shoelace. What would happen to the ends if there were no aglets there to...
Some of the world’s top researchers in the promising field of cancer immunotherapy are gathering in New York this...
Editor’s note: Thursday, Feb. 4, marks World Cancer Day, an annual initiative led by the Union for International Cancer...
The COVID-19 pandemic has taken an enormous global toll. Worldwide, nearly 15 million cases of the disease have been reported,...
The AACR-Bayer Innovation and Discovery Grants program supports researchers who are seeking to develop new treatment options for cancers...
Margaret Foti, PhD, MD (hc), chief executive officer of the American Association for Cancer Research, has been honored with the...
Exercise equivalent to walking just four hours a week reduced a woman’s risk of invasive breast cancer by about...
For World Cancer Research Day, AACR convened a panel of experts to discuss how they are helping to drive...
The cancer research community has made dramatic progress in the past few decades. AACR President David A. Tuveson, MD, PhD, FAACR, cited metastatic melanoma, the...
Dr. Alan D’Andrea spoke about a new grant looking for fresh perspectives in Fanconi anemia-related cancer research.
It looks like a toppled ice cream sundae, with maraschino cherries rolling away from a melting scoop of vanilla....
The era of targeted cancer therapy has fundamentally transformed the way several cancers are treated and has provided new...
Last week, the U.S. Food and Drug Administration (FDA) provided some good news for the breast cancer community just...
While COVID-19 is at the center of medical news, important cancer research findings continue to be reported. As March...
Every month, the editors from the portfolio of scientific journals published by the AACR select one “must read” article...
Among the studies published during the month of October in the nine AACR journals, the editors have chosen to highlight results from two clinical trials of DNA...
Adding denosumab (Xgeva) to adjuvant aromatase inhibitor therapy improved disease-free survival for postmenopausal women with early-stage hormone receptor-positive breast...
The signature pink ribbons of Breast Cancer Awareness Month have become almost as much a part of October as...
Highlights from a workshop and journal article that shared key considerations for including overall survival as an endpoint in...
The prognosis for a patient with cancer depends on several factors, including the cancer’s stage. Patients whose cancers are diagnosed at earlier...
The U.S. Food and Drug Administration (FDA) recently approved expanding the use of the antibody–drug conjugate brentuximab vedotin (Adcetris)...
Early this week, the U.S. Food and Drug Administration (FDA) approved a combination immunotherapy regimen for treating certain patients...
As a predoctoral student in the Integrated Biomedical Sciences Graduate Program at The Ohio State University in 2005, Bethany...
To kick off the new year, the editors of the 10 AACR journals highlighted two phase I clinical trials,...
This week’s excitement surrounding the groundbreaking U.S. Food and Drug Administration (FDA) approval of the CAR T–cell therapy tisagenlecleucel...
By Nicholas Warren, PhD On Thursday, the U.S. Food and Drug Administration (FDA) Center for Tobacco Products (CTP) announced...